When Alzheimer’s steals your sight

What is posterior cortical atrophy?

Posterior cortical atrophy (PCA) is a rare condition most often caused by Alzheimer’s disease but surprisingly, despite often having the same underlying disease, people with PCA have a striking difficulty in seeing what and where things are, while their memory for recent events can still be very good.

The visual symptoms aren’t caused by damage to the eyes, instead people with PCA have damage to areas at the back of the brain called the parietal and occipital lobes. This damage means the brain can’t interpret visual information from the eyes properly, making complex visual tasks like driving and reading particularly difficult. Other skills that rely heavily on the back of the brain, for example spelling and calculation, can also be affected early in the disease.

Why is it important to research PCA?

Practically, we need to research PCA in order to improve the diagnosis and care available for patients and their families and to improve awareness and understanding among healthcare professionals. Because PCA is rare and typically symptoms start in the 50s or 60s (earlier than usual for Alzheimer’s disease), diagnosis is often delayed and problems can be misattributed to anxiety, depression or problems with the eyes. The hope is that by carrying out research and communicating with doctors who may come across patients with PCA, it will become easier for people to get an accurate diagnosis quickly.

Scientifically, PCA raises an interesting question – how can Alzheimer’s disease affect different people in such different ways? This project is a unique opportunity to study PCA and examine what happens in less typical forms of Alzheimer’s. We want to understand why different areas of the brain may be more susceptible to Alzheimer’s, which could explain rarer forms of the disease, but also help to explain more generally why some people are vulnerable to Alzheimer’s and some people aren’t. Recent evidence suggests that the disease may target particular brain areas and the connections between them (known as brain networks). This project provides the opportunity to investigate changes to these connections, and how they differ between different forms of Alzheimer’s.

What’s involved in this project?

The brain is made up of a layer of ‘grey matter’, containing the main cell bodies of brain cells, and underneath that is the ‘white matter’ – the bundles of cables that provide crucial connections through the brain. We know a lot about how the brain’s grey matter is affected by Alzheimer’s, but much less about changes in the white matter.


This project will use a particular brain imaging technique called diffusion tensor imaging that can detect changes in the white matter of the brain. By comparing people with PCA, typical memory-led Alzheimer’s disease and healthy individuals, and investigating changes over time, we hope to improve our knowledge of how the disease spreads through the brain. A better understanding of how white matter is affected in Alzheimer’s may provide new ways of measuring how well therapies work, and could lead to a better understanding of what makes people vulnerable to Alzheimer’s.

Who, where, how much?

I’ll be carrying out the work at the Dementia Research Centre, part of the Institute of Neurology at UCL, under the supervision of Dr Sebastian Crutch and Professor Nick Fox. The Alzheimer’s Research UK research fellowship provides funding of £152,746 to cover research costs for three years.

Want to know more?

If you’re interested in finding out more about PCA, you can read an open-access scientific review or visit the support website for people with PCA, run by UCL.


  1. Vanessa on 19th January 2016 at 5:54 pm

    I am a Experienced Carer and my lady client has PCA and is 70 ,years old she has had the condition for 7 years…

    It is very frustrating no to be able to get any support from community support agency’s as know body appears to know anything about the condition… I have not been able to source any information on how to support this lady…

  2. Sue on 16th September 2016 at 8:59 pm

    There is a good support group for carers run by a group at the Neurological Hospital in Queens Square. If you ring the hospital and ask to be put through to the Dementia Research department they will be able to help.
    My Mum had Posterior Cortical Atrophy for 7 years – she died in 2014. It’s a deeply distressing and frustrating disease – it is a cruel disease. I just know that treating the person with great respect is crucial – it’s very frightening losing your sight, coordination, knowing that you are doing something wrong but not sure what I.e getting a name wrong, unable to pick up an object, unable to say the right words, stumbling when walking and eventually unable to feed yourself or do much for yourself – a great loss of dignity. It’s important that your lady feels valued and respected and cared for – she will need to feel safe and involved in decisions concerning her well being.
    How lovely that as her carer you are trying to find out more about the disease so that you can look after your lady well.

    • Hanna on 27th September 2016 at 10:58 pm

      my sister is 49, she is new with PCA, we live in Denmark – is any international reseach going on ?

  3. Hanna on 30th September 2016 at 7:46 am

    Hello – i am Hanna – confirming my e-mail adress

  4. Hanna on 30th September 2016 at 9:04 am

    Hello – I am Hanna – confirming my e-mail adress.

    Do you know how many people in the world has the PCA ?

    Do we know what kind of medicine is working? – or what else to do?

    In the hospital my sister is the only one!!!!

    Hope to hear from you.

    greetings from Hanna

Leave a Comment

You must be logged in to post a comment.

About the author

Tim Shakespeare

Tim Shakespeare is an Alzheimer's Research UK funded Research Fellow based at the Dementia Research Centre in Queen's Square, part of University College London. In 2013 he began a three-year study to help increase our understanding of posterior cortical atrophy (PCA), a rare condition most often caused by Alzheimer’s disease, using advanced imaging techniques to study changes in the brain.